Le Lézard
Classified in: Health, Business, Covid-19 virus
Subjects: JVN, SRI

The City of Houston Selects DeCurtis Shieldtm to Enhance the Health and Safety of their Facilities


ORLANDO, Fla., Dec. 17, 2020 /PRNewswire-PRWeb/ -- The city of Houston has chosen to install DeCurtis Shieldtm Kiosks at its facilities to improve employees' and guests' safety as part of their new health standards. Kiosks at their entrances will automate the temperature screening process as part of its new robust health and safety practices in response to COVID-19 and future health threats.

"Mayor Turner has taken the proactive lead in mitigating illness for the city of Houston by implementing a health screening solution not only to streamline the process but provide accurate data as part of our new health initiative," said Jane Cheeks, Director, Human Resources. "DeCurtis Shieldtm is a key component to our goal of mitigating the spread of illness and keeping our employees and the citizens of Houston safe"

Houston is the fourth-largest city in the United States. The most recent travel statistics reported that over 3.5 million travelers visited in 2017, and technology to enhance their facilities' health while assisting in mitigating the spread of an outbreak is critical to keep this large metropolis safely open.

"Mayor Turner understands the need for an accurate health screening process as part of their health initiative to provide a safer environment for their employees so they can remain open," said Camille Olivere, Senior Vice President Sales and Marketing, DeCurtis Corporation.
"We are proud to provide patented technology which enables a more accurate and efficient enhancement to the city of Houston's already robust protocols,"

DeCurtis will begin installing DeCurtis Shield immediately.

About DeCurtis Corporation

DeCurtis Corporation is the premier provider of location and proximity enabled solutions in complex indoor environments with a focus on health, safety and security, operational enhancement and experience evolution. Creator of Mobile Assembly Suite (MAStm), the DeCurtis Experience Platform (DXPtm), and DeCurtis Shieldtm, DeCurtis Corporation is the leader in providing transformational experience technology based on decades of deep industry knowledge in the cruise space that is applicable to other sectors. With a vast range of experience working with some of the world's best, most-recognized brands, DeCurtis Corporation transforms the guest experience to be safer, secure and more efficient through the creative application of the latest technology. For more information on DeCurtis Corporation, please visit http://www.decurtis.com.

Media Contact

Stephanie Casimiro, DeCurtis Corporation, 386.451.1194, [email protected]

Twitter

 

SOURCE DeCurtis Corporation


These press releases may also interest you

at 07:05
Gilead Sciences, Inc. and Xilio Therapeutics, Inc. today announced an exclusive license agreement to develop and commercialize Xilio's Phase 1 tumor-activated IL-12 program, XTX301. Xilio Therapeutics is a clinical-stage biotechnology company...

at 07:05
Mannatech, Incorporated , a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its fourth quarter and year ended December 31, 2023. Fourth Quarter Highlights Fourth...

at 07:00
Mayfair Gold Corp. ("Mayfair" or the "Company") today announced the start the 2024 environmental field program in support of a potential environmental assessment for the 100% controlled Fenn-Gib project in the Timmins region of Ontario. The program...

at 07:00
Canadian Solar Inc. (the "Company", or "Canadian Solar") , today issued the following comment: Canadian Solar recently became aware that Maxeon Solar Pte. Ltd. ("Maxeon") has filed a patent infringement lawsuit against Canadian Solar, Inc. in the...

at 07:00
Trilogy Metals Inc.  ("Trilogy Metals" or "the Company") will hold the Company's 2024 Annual General Meeting of the Shareholders ("AGM") on Wednesday, May 22, 2024 at 10:00 am Pacific Time at the office of the Company, Suite 1150, 609 Granville...

at 07:00
CASI Pharmaceuticals, Inc. , a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported business and financial results for the year ended December 31,...



News published on and distributed by: